Home > Insider Trading > Filing (0001022079-17-000120)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1022079	Quest Diagnostics Inc	DGX	Services-Medical Laboratories (8071)	161387862

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1222679	E Michael Prevoznik	C/O Quest Diagnostics Incorporated 3 Giralda Farms Madison NJ 07940	Svp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-04-20	1,013	$55.65	41,335	No	4	M	Direct
Common Stock	Disposition	2017-04-20	1,013	$100.00	40,322	No	4	S	Direct
Common Stock	Acquisiton	2017-04-20	28,500	$56.82	68,822	No	4	M	Direct
Common Stock	Disposition	2017-04-20	28,500	$100.00	40,327	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (Right to Buy)	Acquisiton	2017-04-20	1,013	$55.65	1,013	$55.65
Common Stock	Stock Options (Right to Buy)	Acquisiton	2017-04-20	28,500	$56.82	28,500	$56.82

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-02-10	No	4	M	Direct
0		2021-02-15	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,792	Indirect	401(k)/SDCP

Footnotes

This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 10, 2017.
The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
The options vested in three equal annual installments beginning with the first on February 10, 2011, the second on February 10, 2012 and the final on February 10, 2013.
The options vested in three equal annual installments beginning with the first on February 15, 2012, the second on February 15, 2013 and the final on February 15, 2014.